Stockreport

BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., March 21, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardio [Read more]